Oncorus Revenue and Competitors
Estimated Revenue & Valuation
- Oncorus's estimated annual revenue is currently $18.8M per year.
- Oncorus's estimated revenue per employee is $852,500
- Oncorus's total funding is $198.5M.
Employee Data
- Oncorus has 22 Employees.
- Oncorus grew their employee count by -78% last year.
Oncorus's People
| Name | Title | Email/Phone |
|---|---|---|
1 | COO and Chief Staff | Reveal Email/Phone |
2 | VP Research | Reveal Email/Phone |
3 | Associate Director, GMP Facilities | Reveal Email/Phone |
4 | QA Specialist Trainer | Reveal Email/Phone |
5 | Principal Associate Scientist, Upstream Process Development | Reveal Email/Phone |
6 | President & CEO | Reveal Email/Phone |
7 | Principal Associate Scientist | Reveal Email/Phone |
8 | N/A | Reveal Email/Phone |
9 | Senior Associate Scientist, Upstream Process Development | Reveal Email/Phone |
10 | Senior Director Corporate Strategy and Business Development | Reveal Email/Phone |
Oncorus Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Oncorus?
Oncorus is a pre-clinical stage biotechnology company developing innovative and impactful, next-generation oncolytic HSV products with unprecedented potential to recruit all arms of immune system to treat solid tumors. The Oncorus family is dedicated to bringing hope and impactful therapies to cancer patients everywhere. As part of our commitment, we have taken a pledge to donate a portion of product sales to fund promising cancer research and to support cancer care in the developing world.
keywords:N/A
$198.5M
Total Funding
22
Number of Employees
$18.8M
Revenue (est)
-78%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Oncorus News
Oncorus posted earnings of ($0.53) per share in the same quarter last year, which suggests a negative year over year growth rate of 47.2%. The...
Oncorus' vRNA Immunotherapy Platform encapsulates the genomes of RNA viruses known to kill cancer cells within an LNP, producing a living...
-Multiple tranche debt financing agreement provides Oncorus with access to up to $45 million-. -Use of proceeds intended to support...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.2M | 22 | -61% | N/A |
#2 | $2.8M | 22 | -4% | $96M |
#3 | $1.5M | 22 | 10% | N/A |
#4 | $2M | 22 | -19% | N/A |
#5 | $2.8M | 22 | 5% | N/A |